Connection

Silvio Danese to Janus Kinase Inhibitors

This is a "connection" page, showing publications Silvio Danese has written about Janus Kinase Inhibitors.
Connection Strength

0.959
  1. Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials. Expert Opin Investig Drugs. 2018 07; 27(7):595-599.
    View in: PubMed
    Score: 0.481
  2. JAK inhibitors: Novel developments in management of ulcerative colitis. Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:89-93.
    View in: PubMed
    Score: 0.477
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.